In this article, I will be taking a look back at 2019 – our first full year as RxNet. This year we took full advantage of our expanded scope, bringing you the most interesting and noteworthy breaking news in drug discovery, keeping you up to date with the latest drug approvals and providing you with expert interviews and articles – all for FREE!
RxN Glossary of Drug Discovery
Throughout 2019, the RxNet editorial team were working very hard behind the scenes to put together the first edition of the RxNet Glossary of Drug Discovery. Together with leading experts from both industry and academia, we came together to provide a comprehensive overview of that reflects this industry as a whole. We hope that this resource is of benefit to everyone working within the drug discovery and related fields, as well as one that can act as a bridge between scientists working within drug discovery and the general public.
Click here, to access the glossary for free
This year we covered two topics as part of our two-month-long ‘Spotlights’. In these we took a deep dive, looking into some of the latest developments, the challenges researchers are currently facing and postulated where these fields are heading.
Kicking off the year, we started with preclinical testing. In this, we investigated at how the 3Rs can be applied to preclinical research with Anthony Holmes (National Center for the Replacement, Refinement and Reduction of Animals in Research; London, UK) and sought to learn more about the role of organoids in drug discovery in this interview with Rob Vries (Hubrecht Organoid Technology; Utrecht, Netherlands).
5 months later, we turned to the field of biophysics. We spoke with a number of experts to discuss the work they are undertaking utilizing the biophysical imaging, such as NMR spectroscopy, x-ray crystallography and cryo-electron microscopy, to aid their research endeavors. Additionally, we also found out how biophysics aided antibiotic drug discovery.
In January, RxNet had the pleasure of attending the Antimicrobial Chemotherapy Conference (15 January 2019; London, UK). This was the first conference I had ever attended, and it was a great one to start on – hearing a range of talks on the research and discovery of new antimicrobial. You can check out my conference report here.
As well as this, RxNet also attended the Fall edition of the ACS National Meeting & Expo (25–29 August 2019; CA, USA), the 4th Medicinal Chemistry & Protein Degradation Summit (28–29 October 2019; London, UK) and AAPS 2019 PharmSci 360. Wherever we went this year, it was great meeting old and new members of the site. Be sure to keep an eye out to see where we are heading in 2020, for a chance to meet us and to grab your free copy of the Glossary.
If you want to know what conferences, summits and events are happening in 2020, be sure to check out our events calendar here.
Continuing our partnership with our affiliated journals, we upped the content available for our members to access.
We’ve been regularly publishing the patent highlights, from Pharmaceutical Patent Analyst, where Hermann Mucke (H.M. Pharma Consultancy; Wein, Austria) has been providing us with noteworthy developments in the patent literature.
Excitingly, our latest partner journal, Future Drug Discovery, launched in March! To commemorate this, we published a two-part interview. In the first, Francesca Lake (Managing Editor, Future Drug Discovery) introduced us to the journal and the second was a Peek behind the Paper interview with the corresponding author of the first article published in the journal.
Speaking of Peek behind the Paper interviews, we’ve heard from a wonderful variety of authors to discuss their research or articles further, highlights include one researcher’s efforts to use a drug repurposing approach to improving cancer therapies and another on how nose-to-brain delivery could be a better route for efficient drug delivery into the central nervous system.
2020: a new decade…
It’s been a great year for RxNet, and things can only get better as we begin 2020 and enter into a new decade. We’ve got a lot of big plans for the next year and we hope you continue to enjoy all the content we produce. As always, a huge thank you to all of our members, readers and contributors – the site would not be the same without you!